These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2800645)

  • 21. Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strains.
    Fuchs PC; Barry AL; Jones RN; Thornsberry C
    Diagn Microbiol Infect Dis; 1984 Jan; 2(1):55-63. PubMed ID: 6443203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France.
    Farfour E; Si Larbi AG; Cattoir V; Corvec S; Guillard T; Grillon A; Isnard C; Mérens A; Degand N; Billard-Pomares T; Fournier D; Bille E; Le Brun C; Plouzeau C; Flevin E; Yin N; Woerther PL; Lourtet J; Lesprit P; Le Monnier A;
    Diagn Microbiol Infect Dis; 2021 Jul; 100(3):115368. PubMed ID: 33813355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temocillin against Enterobacteriaceae.
    Colaert J
    Acta Clin Belg; 1993; 48(6):415-6. PubMed ID: 8128823
    [No Abstract]   [Full Text] [Related]  

  • 24. Extended spectrum beta lactamase--mediated resistance among isolates of family Enterobacteriaceae.
    Deep ; Arora U
    Indian J Pathol Microbiol; 2007 Apr; 50(2):458-61. PubMed ID: 17883109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of temocillin against gram-negative clinical isolates.
    Gaya H; Hutchinson GR; Chadwick MV
    Drugs; 1985; 29 Suppl 5():15-7. PubMed ID: 3875472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
    De Jongh R; Hens R; Basma V; Mouton JW; Tulkens PM; Carryn S
    J Antimicrob Chemother; 2008 Feb; 61(2):382-8. PubMed ID: 18070831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bactericidal activity of tigemonam, alone and in combination with gentamicin.
    Shah PM; Gänger-Farshid G; Mulert R; Stille W
    J Chemother; 1989 May; 1 Suppl 2():45-8. PubMed ID: 2809703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
    Quentin C; Sageaux JC; Bebear C; Latrille J
    Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of gentamycin combined with beta-lactam antibiotics against penicillin-resistant and non-resistant Streptococcus agalactiae].
    Villar H; Jugo M; Farinati A
    Enferm Infecc Microbiol Clin; 1994 Oct; 12(8):385-9. PubMed ID: 7981289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.
    Kayser FH; Novak J
    Am J Med; 1987 Apr; 82(4A):33-9. PubMed ID: 3555058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temocillin susceptibility by BSAC methodology.
    Andrews JM; Jevons G; Walker R; Ashby J; Fraise AP
    J Antimicrob Chemother; 2007 Jul; 60(1):185-7. PubMed ID: 17550891
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K; Dickert H; Braveny I
    Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The place of temocillin in the treatment of hospital infections.
    Williams JD; Chen HY
    Drugs; 1985; 29 Suppl 5():234-9. PubMed ID: 3875473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The first isolate of Tatumella ptyseos in Malaysia.
    Tan SC; Wong YH; Jegathesan M; Chang SM
    Malays J Pathol; 1989 Aug; 11():25-7. PubMed ID: 2632996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrice-weekly temocillin administered after each dialysis session is appropriate for the treatment of serious Gram-negative infections in haemodialysis patients.
    Vandecasteele SJ; Miranda Bastos AC; Capron A; Spinewine A; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2015 Dec; 46(6):660-5. PubMed ID: 26603304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding to and antibacterial effect of aztreonam, temocillin, gentamicin and tobramycin on human faeces.
    Hazenberg MP; Pennock-Schröder AM; van de Merwe JP
    J Hyg (Lond); 1985 Oct; 95(2):255-63. PubMed ID: 4067288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of complicated and uncomplicated urinary tract infections with temocillin.
    Kosmidis J
    Drugs; 1985; 29 Suppl 5():172-4. PubMed ID: 4029023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of temocillin on human bowel flora.
    Mittermayer HW
    Drugs; 1985; 29 Suppl 5():43-8. PubMed ID: 3849424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRL 20330, an oral prodrug of temocillin: bioavailability studies in man.
    Basker MJ; Merrikin DJ; Ponsford RJ; Slocombe B; Tasker TC
    J Antimicrob Chemother; 1986 Sep; 18(3):399-405. PubMed ID: 3095301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.